Mynd Life SciencesAug 26, 2021MYND Life Sciences Announces $3 Million Convertible Debenture Unit OfferingVANCOUVER, BC, Aug. 26, 2021 /PRNewswire/ – MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) (“MYND” or the “Company“), is pleased to...
Mynd Life SciencesAug 11, 2021MYND Life Sciences Announces DTC EligibilityVANCOUVER, BC, Aug. 11, 2021 /PRNewswire/ – MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) (“MYND”) is a drug research and development...
Mynd Life SciencesJul 7, 2021MYND Life Sciences Provides Corporate UpdateVANCOUVER, BC, July 7, 2021 /PRNewswire/ – MYND Life Sciences Inc. (CSE: MYND) (“MYND”) is a drug research and development company...